For developing any natural product for clinical application we need to comprehensively understand and identify its molecular targets and mode of action. The rapid advancement of high throughput screening, structural elucidation and combinatorial synthesis have revitalized the potential of plant derived compounds as chemotherapeutic agents against cancer, and Computational screening programs such as molecular docking has greatly helped in rapid screening of chemical entities against their macromolecular targets(Gurung, Bhattacharjee and Ali, 2016). Such as in silico toxicity screens have routinely been employed in drug discovery pipelines to study the pharmacokinetic and pharmacodynamics properties of the selected drug like compounds before proceeding to experimental trials.